Diabetes decisions — 2025

The Board remands the claims for service connection for hypothyroidism and diabetes mellitus as additional medical opinions are needed to address the etiology of these conditions.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, bilateral upper extremity neuropathy, bilateral lower extremity neuropathy, and prostate cancer due to duty to assist errors.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, as the November 2023 TERA opinions are inadequate.

The Board granted an earlier effective date for service connection of diabetic retinopathy and a total disability rating based on individual unemployability, while denying increased ratings for diabetic nephropathy and diabetes mellitus II with erectile dysfunction.

The appeal for service connection for diabetes mellitus, ischemic heart disease, a kidney condition, sinus bradycardia, a skin rash, a bladder disability, and an enlarged prostate was dismissed due to the Veteran's untimely filing of a VA Form 10182.

The Board granted an effective date of November 19, 2021, for the award of service connection for hypertension and granted ratings for various disabilities including a 10 percent rating for hypertension prior to July 5, 2023, and a 40 percent rating for diabetic peripheral neuropathy in both lower extremities.

The Board granted an earlier effective date of June 18, 2018 for the awards of service connection for diabetes mellitus type II and obstructive sleep apnea.

Service connection for the cause of the Veteran's death is granted due to a significant contribution from his service-connected diabetes mellitus.

The Board denied the veteran's claims for increased ratings for various service-connected conditions, including anxiety disorder, diabetes mellitus, obstructive sleep apnea, peripheral neuropathy, and gastroesophageal reflux disease.

The Board granted service connection for seborrheic dermatitis and actinic keratosis with an effective date of March 13, 2020, and a 10 percent rating. The claim for an earlier effective date for GERD was dismissed, and the TDIU was granted from August 10, 2022.

The Veteran's service-connected PTSD was granted an increased initial rating of 70 percent, and TDIU and SMC were also granted from January 26, 2016. Service connection for diabetes mellitus type II, peripheral neuropathy, bilateral upper and lower extremities, prostate disorder, sleep apnea, and Parkinson's-like symptoms was denied.

The Board remands the claims for service connection for diabetes mellitus, type II, left and right upper extremity peripheral neuropathy, an acquired psychiatric disorder, other than PTSD, and PTSD due to a lack of proper VA examinations and verification of in-service herbicide exposure.

The Board denied service connection for various conditions, including pseudofolliculitis barbae, right and left knee disorders, chronic fatigue, residuals of a left hand fracture, vertigo, and others. The claims were not remanded for further development.

The Board remands the case for an additional examination to determine the combined effects of the Veteran's service-connected disabilities and any resulting impairment, specifically addressing whether his service-connected disabilities result in discomfort and pain that make it difficult for him to get adequate rest and affect his ability to handle workplace stress.

The Board granted earlier effective dates for the grants of service connection for chronic adjustment disorder, diabetes mellitus, type II, and bilateral lower extremity diabetic peripheral neuropathy.

The Board denied the Veteran's claim for service connection for diabetes mellitus, finding that the evidence does not support a link between the Veteran's diabetes and his military service or any service-connected disabilities.

The Board granted a 70 percent rating for PTSD and a total disability rating based on individual unemployability, while denying increased ratings for diabetes mellitus type II and diabetic neuropathy of the sciatic and femoral nerves.

The Board reopened the claim for service connection for pneumonia and bronchitis, but dismissed the claim for a lumbar spine disability. The remaining claims were remanded for further development.

The Board denied the Veteran's claims for service connection for type II diabetes mellitus and hypertension as secondary to PTSD, finding that the evidence did not support a causal or aggravating relationship between the disabilities and the service-connected PTSD.

The Board granted a 60 percent rating for Diabetes Mellitus II and all related complications, including erectile dysfunction.